Hepatitis C Drug Head-To-Head Comparative Studies Debated At PCORI Workshop
This article was originally published in The Pink Sheet Daily
Executive Summary
There appeared to be support for the idea that if head-to-head studies are funded, they should focus on “high risk populations,” such as intravenous drug users.